Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (22)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Chen, L.-Y.
Right arrow Articles by Chou, J. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, L.-Y.
Right arrow Articles by Chou, J. Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2002, Vol. 11, No. 25 3199-3207
© 2002 Oxford University Press

Structure–function analysis of the glucose-6-phosphate transporter deficient in glycogen storage disease type Ib

Li-Yuan Chen{dagger}, Chi-Jiunn Pan{dagger}, Jeng-Jer Shieh and Janice Yang Chou*

Section on Cellular Differentiation, Heritable Disorders Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, 20892

Received August 10, 2002; Revised September 25, 2002; Accepted September 30, 2002

Glycogen storage disease type Ib (GSD-Ib) is caused by a deficiency in the glucose-6-phosphate transporter (G6PT), a 10 transmembrane domain endoplasmic reticulum protein. To date, 69 G6PT mutations, including 28 missenses and 2 codon deletions, have been identified in GSD-Ib patients. We previously characterized 15 of the missense and one codon deletion mutations using a pSVL-based expression assay. A lack of sensitivity in this assay limited the discrimination between mutations that lead to loss of function and mutations that leave a low residual activity. We now report an improved G6PT assay, based on an adenoviral vector-mediated expression system and its use in the functional characterization of all 30 codon mutations found in GSD-Ib patients. Twenty of the naturally occurring mutations completely abolish microsomal G6P uptake activity while the other 10 mutations, including 5 previously characterized ones, partially inactivate the transporter. This information should greatly facilitate genotype–phenotype correlation. We also report a structure–function analysis of G6PT. In addition to the 3 destabilizing mutations reported previously, we now show that the G50R, C176R, V235del, G339C and G339D mutations also compromise the G6PT stability. Mutation analysis of the amino-terminal domain of G6PT shows that it is required for optimal G6P uptake activity. Finally, we show that degradation of both wild-type and mutant G6PT is inhibited by a potent proteasome inhibitor, lactacystin, demonstrating that G6PT is a substrate for proteasome-mediated degradation.

* To whom correspondence should be addressed at: Building 10, Room 9S241, NIH, Bethesda, MD 20892-1830, USA. Tel: +3014961094; Fax: +3014026035; Email: chou{at}helix.nih.gov

{dagger} The authors wish it to be known that, in their opinion, these authors should be considered as joint First Authors.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
FASEB J.Home page
S.-Y. Chen, C.-J. Pan, K. Nandigama, B. C. Mansfield, S. V. Ambudkar, and J. Y. Chou
The glucose-6-phosphate transporter is a phosphate-linked antiporter deficient in glycogen storage disease type Ib and Ic
FASEB J, July 1, 2008; 22(7): 2206 - 2213.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
S. Fortier, M. Touaibia, S. Lord-Dufour, J. Galipeau, R. Roy, and B. Annabi
Tetra- and hexavalent mannosides inhibit the pro-apoptotic, antiproliferative and cell surface clustering effects of concanavalin-A: Impact on MT1-MMP functions in marrow-derived mesenchymal stromal cells
Glycobiology, February 1, 2008; 18(2): 195 - 204.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-C. Currie, S. Fortier, A. Sina, J. Galipeau, J. Cao, and B. Annabi
MT1-MMP Down-regulates the Glucose 6-Phosphate Transporter Expression in Marrow Stromal Cells: A MOLECULAR LINK BETWEEN PRO-MMP-2 ACTIVATION, CHEMOTAXIS, AND CELL SURVIVAL
J. Biol. Chem., March 16, 2007; 282(11): 8142 - 8149.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Javot, R. V. Penmetsa, N. Terzaghi, D. R. Cook, and M. J. Harrison
A Medicago truncatula phosphate transporter indispensable for the arbuscular mycorrhizal symbiosis
PNAS, January 30, 2007; 104(5): 1720 - 1725.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-J. Shieh, C.-J. Pan, B. C. Mansfield, and J. Y. Chou
A Glucose-6-phosphate Hydrolase, Widely Expressed Outside the Liver, Can Explain Age-dependent Resolution of Hypoglycemia in Glycogen Storage Disease Type Ia
J. Biol. Chem., November 21, 2003; 278(47): 47098 - 47103.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
L.-Y. Chen, J.-J. Shieh, B. Lin, C.-J. Pan, J.-L. Gao, P. M. Murphy, T. F. Roe, S. Moses, J. M. Ward, E. J. Lee, et al.
Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter
Hum. Mol. Genet., October 1, 2003; 12(19): 2547 - 2558.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
Y. Huang, M. J. Lemieux, J. Song, M. Auer, and D.-N. Wang
Structure and Mechanism of the Glycerol-3-Phosphate Transporter from Escherichia coli
Science, August 1, 2003; 301(5633): 616 - 620.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.